#Talk
How Is a Medicine Made?
From the initial idea to final approval, experts from Fraunhofer ITMP and the Paul-Ehrlich-Institut will explain the key stages of drug development in this moderated discussion, including how effectiveness is evaluated, why the process takes time, and how research institutions and regulatory authorities work together.
Sept. 19th. 2026
11:00-11:30 am
Stage
Audience members are invited to ask questions and join the conversation.
Featuring:
Prof. Dr. med. Frank Behrens, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP
Prof. (apl.) Dr. Zoe Waibler, Paul-Ehrlich-Institut, German Federal Institute for Vaccines and Biomedicines
About the speakers:
Prof. Dr. med. Frank Behrens is a rheumatologist and an expert in translational medicine, immunology, and inflammation research at Goethe University Frankfurt. He also heads the Rheumatology division at University Medicine Frankfurt. At the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, he leads the Clinical Research division and serves as Deputy Institute Director.
Prof. (apl.) Dr. Zoe Waibler is Vice President of the Paul-Ehrlich-Institut, the German Federal Institute for Vaccines and Biomedicines, Head of the Product Testing of Immunological Medicinal Products Division, and Head of the Immunological and Biopharmaceutical Research Group. She is also an adjunct professor in the Department of Biosciences at Goethe University Frankfurt, where her research focuses on immunology.
Feedback geben